ENTITY

Adaptimmune Therapeutics (ADAP US)

3
Analysis
Health CareUnited States
Adaptimmune Therapeutics plc is a clinical-stage biopharmaceutical company. The Company develops novel cancer immunotherapy products based on T-cell receptor platform that helps to identify cancer targets. Adaptimmune Therapeutics serves customers worldwide.
more
Company Event05 Mar 2025 15:00 • Upcoming
Add To Calendar
Company Event19 Nov 2024 03:30 • Latest
Company Event14 Nov 2024 05:30
Company Event12 Aug 2024 20:00
x